One Day In July LLC Has $422,000 Stock Position in Danaher Co. (NYSE:DHR)

One Day In July LLC lowered its holdings in shares of Danaher Co. (NYSE:DHR) by 43.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,837 shares of the conglomerate’s stock after selling 1,413 shares during the period. One Day In July LLC’s holdings in Danaher were worth $422,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the business. Kovack Advisors Inc. boosted its holdings in shares of Danaher by 3.4% in the third quarter. Kovack Advisors Inc. now owns 1,243 shares of the conglomerate’s stock worth $346,000 after acquiring an additional 41 shares during the period. Gilbert & Cook Inc. boosted its holdings in shares of Danaher by 2.5% in the fourth quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock worth $401,000 after acquiring an additional 42 shares during the period. Grimes & Company Inc. boosted its holdings in shares of Danaher by 0.6% in the fourth quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock worth $1,696,000 after acquiring an additional 43 shares during the period. Harbour Investments Inc. boosted its holdings in shares of Danaher by 3.0% in the third quarter. Harbour Investments Inc. now owns 1,531 shares of the conglomerate’s stock worth $426,000 after acquiring an additional 45 shares during the period. Finally, Dakota Community Bank & Trust NA boosted its holdings in shares of Danaher by 16.4% in the fourth quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock worth $73,000 after acquiring an additional 45 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. Jefferies Financial Group cut their price target on Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a report on Wednesday, January 29th. Robert W. Baird dropped their price objective on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Citigroup dropped their price objective on Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research note on Thursday, January 30th. Scotiabank started coverage on Danaher in a research note on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price objective for the company. Finally, Barclays dropped their price objective on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Seven research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Stock Up 1.5 %

DHR opened at $208.10 on Friday. The company has a market cap of $150.31 billion, a P/E ratio of 39.41, a P/E/G ratio of 2.61 and a beta of 0.83. The business’s 50-day moving average price is $227.21 and its 200-day moving average price is $247.52. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the company earned $2.09 EPS. On average, equities analysts expect that Danaher Co. will post 7.67 EPS for the current year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is currently 20.45%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.